Cumberland Pharmaceuticals (CPIX) Misses Q3 EPS by 10c

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of $0.01, $0.10 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $10.4 million versus the consensus estimate of $12.65 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• CoStar Group acquires Zonda for $800M, adding new home data